CD8A and cancer: First, they reduced the number of CD8+ T cells in mice with sgNT and sgCda tumors receiving anti-PD-1 treatment and discovered that the CDA-depleted cancer cells had lost their ability to attract macrophages and maintain their immunosuppressive phenotype.